Ken Griffin Jasper Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$0.68 - $1.54 $204 - $462	-300 Reduced 75.0%	100 $0
Q2 2023 Aug 14, 2023	SELL	$1.19 - $1.79 $3,927 - $5,907	-3,300 Reduced 89.19%	400 $0
Q1 2023 May 15, 2023	BUY	$1.48 - $2.74 $4,144 - $7,672	2,800 Added 311.11%	3,700 $6,000
Q4 2022 Feb 14, 2023	BUY	$0.46 - $8.9 $414 - $8,010	900 New	900 $0

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $843M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.